首页> 外文学位 >Photochemical and spectroscopic studies of ruthenium(II) complexes as potential photodynamic therapy agents.
【24h】

Photochemical and spectroscopic studies of ruthenium(II) complexes as potential photodynamic therapy agents.

机译:钌(II)配合物作为潜在的光动力治疗剂的光化学和光谱学研究。

获取原文
获取原文并翻译 | 示例

摘要

Cisplatin is an anticancer drug used in the treatment of various cancers. However, cisplatin is toxic towards both healthy and tumor cells alike, resulting in several undesirable side effects. Moreover, some of the most aggressive cancers develop resistance to cisplatin. Photodynamic therapy (PDT) uses light to localize activation of otherwise non-toxic compounds in tumor tissue. Current PDT agents achieve toxicity by the photosensitization of highly reactive singlet oxygen through energy transfer from an excited state. However, this need for the presence of molecular oxygen represents a disadvantage since malignant and drug resistant cells are often hypoxic. To address the drawbacks of cisplatin and PDT drugs as antitumor agents, a combined approach has been made with the development of several photoactive Ru(II) complexes that produced with antitumor activity under irradiation. This blend of cisplatin mimetic metal complexes, inorganic photochemistry and photodynamic therapy has led to the discovery of several photo-activated ruthenium complexes that bind DNA in a manner similar to cisplatin. This new class of compounds is referred to as photo-cisplatin analogs.;A successful PDT agent should possess high molar absorbtivity at long wavelengths where tissue penetration is greatest and there is low absorption by biomolecules. A series of Ru(II) complexes were synthesized with the deprotonated forms of the ligands 8-hydroxyquinoline (quo--) and 5-NO 2-8-hydroxyquinolate (5-NO2-quo--) as analogs to the prototypical complex [Ru(bpy)3]2+ (bpy = 2, 2'-bipyridine) in order to red shift absorption of the new complexes into the optimized PDT window. Electrochemistry, spectroscopy and density functional theory calculations were utilized to investigate the electronic tuning of the occupied t2g-type orbitals of the metal center with variation in the ligation sphere. The maximum of the lowest energy absorption of complexes containing one, two and three 8-quinolate ligands progressively red shifts from 452 nm in [Ru(bpy)3]2+ to 510 nm in [Ru(bpy)2(quo)]+, 515 nm in [Ru(bpy)(quo) 2], and 540 nm in [Ru(quo)3]-- in water. This bathochromic shift results from the increase in energy of the occupied t2g-type orbital across the series afforded by coordination of each subsequent quo-- ligand to the Ru(II) center. TD-DFT calculations along with electrochemical analysis reveals that the lowest energy transition has contributions in the HOMO from both the quo-- ligand and the metal, such that the lowest energy transition is not from an orbital that is purely metal-centered in character as in [Ru(bpy)3] 2+.;The photolabile complex cis-[Ru(phpy)(phen)(CH 3CN)2]+ (4, phpy-- = 2-phenylpyridine, phen = 1,10-phenantrholine) was investigated as a potential photodynamic therapy (PDT) agent. A low energy transition assigned as Ru-phen MLCT was observed with a broad tail extending into the PDT window (600--850 nm). Irradiation of 4 with long wavelengths (lambda irr ≥ 630 nm) resulted in photoinduced ligand exchange of the monodentate acetonitrile ligands with quantum yield (phiCl) of 0.25 (lambda irr = 450 nm) for the photosubstitution by chloride in CH2Cl 2 to generate [Ru(phpy)(phen)(CH3CN)Cl]. This value is similar to that previously reported for the photosubstitution by chloride in CH 2Cl2 in cis-[Ru(bpy)2(CH 3CN)2] 2+ (3, bpy= 2, 2'-bipyridine) phi = 0.31 (lambdairr = 430 nm). A dependence of the quantum yield of ligand exchange on the wavelength of irradiation was observed for 4. Selective irradiation into the Ru-phen 1MLCT (lambda irr = 500 nm) of 4 results in more efficient ligand substitution (phi = 0.25) as compared to irradiation into the Ru-phpy 1MLCT peak (lambdairr = 450 nm; phi = 0.08) for chloride in CH 2Cl2. It is generally accepted that ligand dissociation occurs from the M--L (sigma*) antibonding metal centered 3LF state(s). Therefore, a small energy gap between the lowest energy Ru→phen 3MLCT state(s) and 3LF state is proposed. In addition, the lower quantum yield observed for irradiation in to the Ru→phpy 3MLCT is believed to result from the rapid deactivation of the excited species through strong metal-ligand orbital overlap between phpy- and the metal center.
机译:顺铂是一种用于治疗各种癌症的抗癌药物。然而,顺铂对健康细胞和肿瘤细胞均具有毒性,导致几种不良副作用。此外,一些最具侵略性的癌症对顺铂产生耐药性。光动力疗法(PDT)使用光来定位肿瘤组织中原本无毒的化合物的活化。当前的PDT剂通过从激发态的能量转移对高反应性单线态氧进行光敏而达到毒性。然而,由于恶性和耐药性细胞通常是低氧的,因此需要存在分子氧代表了一个缺点。为了解决顺铂和PDT药物作为抗肿瘤剂的缺点,已经开发了一种结合的方法,即开发了几种在辐射下具有抗肿瘤活性的光活性Ru(II)复合物。顺铂模拟金属配合物,无机光化学和光动力疗法的这种混合导致发现了几种以类似于顺铂的方式结合DNA的光活化钌配合物。这类新化合物称为光顺铂类似物。成功的PDT试剂应在长波长下具有较高的摩尔吸光度,在长波长下组织穿透力最大,而生物分子的吸收率低。合成了一系列Ru(II)配合物,它们的去质子化形式有8-羟基喹啉(quo--)和5-NO 2-8-羟基喹啉酸酯(5-NO2-quo--)作为原型复合物的类似物[ Ru(bpy)3] 2+(bpy = 2,2'-联吡啶),以便将新配合物的吸收红移到优化的PDT窗口中。利用电化学,光谱学和密度泛函理论计算来研究金属中心占据的t2g型轨道在连接球中的变化情况下的电子调谐。包含一个,两个和三个8-喹啉酸酯配体的配合物的最低能量吸收最大值从[Ru(bpy)3] 2+中的452 nm逐渐红移到[Ru(bpy)2(quo)] +中的510 nm。 ,在[Ru(bpy)(quo)2]中为515 nm,在[Ru(quo)3]中为540 nm。这种红移是由于每个随后的quo配体与Ru(II)中心的配位所提供的,整个系列中被占据的t2g型轨道的能量增加所致。 TD-DFT计算和电化学分析表明,最低的能量跃迁对quomo配体和金属的HOMO都有贡献,因此最低的能量跃迁不是来自纯粹以金属为中心的轨道在[Ru(bpy)3] 2+中;光不稳定复合物顺式[[Ru(phpy)(phen)(CH 3CN)2] +(4,phpy-- = 2-苯基吡啶,phen = 1,10-菲咯啉)被作为潜在的光动力疗法(PDT)药物进行了研究。观察到分配为Ru-phen MLCT的低能量跃迁,宽尾巴延伸到PDT窗口(600--850 nm)中。辐射4个长波长(λirr≥630 nm)会导致单齿乙腈配体的光诱导配体交换,量子产率(phiCl)为0.25(λirr = 450 nm),从而使氯化物在CH2Cl 2中产生光分解[Ru] (phpy)(phen)(CH3CN)Cl]。该值类似于先前报道的在顺式-[Ru(bpy)2(CH 3CN)2] 2+(3,bpy = 2,2'-bipyridine)phi = 0.31(lambdairr)中CH 2Cl2中氯化物光解的值= 430 nm)。对于4,观察到配体交换的量子产率对照射波长的依赖性。对Ru-phen 1MLCT(λirr = 500 nm)进行选择性照射,与4相比,可以更有效地进行配体取代(phi = 0.25)。辐射到CH 2Cl2中氯化物的Ru-phpy 1MLCT峰(lambdairr = 450 nm; phi = 0.08)中。通常认为配体解离发生在以ML(sigma *)反键金属为中心的3LF状态。因此,提出了最低能量Ru→phen 3MLCT状态与3LF状态之间的小能隙。另外,据信辐照到Ru→phpy 3MLCT中观察到的较低的量子产率是由于通过phpy-与金属中心之间强烈的金属-配体轨道重叠而使受激物种快速失活所致。

著录项

  • 作者

    Sears, R. Bryan.;

  • 作者单位

    The Ohio State University.;

  • 授予单位 The Ohio State University.;
  • 学科 Chemistry Inorganic.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 198 p.
  • 总页数 198
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号